Literature DB >> 23937344

Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.

Sikhulile Moyo1, Tessa LeCuyer, Rui Wang, Simani Gaseitsiwe, Jia Weng, Rosemary Musonda, Hermann Bussmann, Madisa Mine, Susan Engelbrecht, Joseph Makhema, Richard Marlink, Marianna K Baum, Vladimir Novitsky, M Essex.   

Abstract

Laboratory cross-sectional assays are useful for the estimation of HIV incidence, but are known to misclassify individuals with long-standing infection as recently infected. The false recent rate (FRR) varies widely across geographic areas; therefore, accurate estimates of HIV incidence require a locally defined FRR. We determined FRR for Botswana, where HIV-1 subtype C infection is predominant, using the BED capture enzyme immunoassay (BED), a Bio-Rad Avidity Index (BAI) assay (a modification of the Bio-Rad HIV1/2+O EIA), and two multiassay algorithms (MAA) that included clinical data. To estimate FRR, stored blood samples from 512 antiretroviral (ARV)-naive HIV-1 subtype C-infected individuals from a prospective cohort in Botswana were tested at 18-24 months postenrollment. The following FRR mean (95% CI) values were obtained: BED 6.05% (4.15-8.48), BAI 5.57% (3.70-8.0), BED-BAI 2.25% (1.13-4.0), and a combination of BED-BAI with CD4 (>200) and viral load (>400) threshold 1.43% (0.58-2.93). The interassay agreement between BED and BAI was 92.8% (95% CI, 90.1-94.5) for recent/long-term classification. Misclassification was associated with viral suppression for BED [adjusted OR (aOR) 10.31; p=0.008], BAI [aOR 9.72; p=0.019], and MAA1 [aOR 16.6; p=0.006]. Employing MAA can reduce FRR to <2%. A local FRR can improve cross-sectional HIV incidence estimates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23937344      PMCID: PMC3887420          DOI: 10.1089/aid.2013.0055

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  35 in total

1.  Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion.

Authors:  Trudy Dobbs; Susan Kennedy; Chou-Pong Pau; J Steven McDougal; Bharat S Parekh
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.

Authors:  John W Hargrove; Jean H Humphrey; Kuda Mutasa; Bharat S Parekh; J Steve McDougal; Robert Ntozini; Henry Chidawanyika; Lawrence H Moulton; Brian Ward; Kusum Nathoo; Peter J Iliff; Ekkehard Kopp
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

3.  Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.

Authors:  Xierong Wei; Xin Liu; Trudy Dobbs; Debra Kuehl; John N Nkengasong; Dale J Hu; Bharat S Parekh
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

4.  The value of AIDS incidence data in assessing the spread of HIV infection.

Authors:  V De Gruttola; S W Lagakos
Journal:  Stat Med       Date:  1989-01       Impact factor: 2.373

5.  Using tests for recent infection to estimate incidence: problems and prospects for HIV.

Authors:  A Welte; T A McWalter; O Laeyendecker; T B Hallett
Journal:  Euro Surveill       Date:  2010-06-17

6.  Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.

Authors:  A Chawla; G Murphy; C Donnelly; C L Booth; M Johnson; J V Parry; A Phillips; A M Geretti
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

7.  HIV incidence determination in the United States: a multiassay approach.

Authors:  Oliver Laeyendecker; Ron Brookmeyer; Matthew M Cousins; Caroline E Mullis; Jacob Konikoff; Deborah Donnell; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Shruti H Mehta; Jacquie Astemborski; Lisa P Jacobson; Joseph B Margolick; Joelle Brown; Thomas C Quinn; Susan H Eshleman
Journal:  J Infect Dis       Date:  2012-11-05       Impact factor: 5.226

8.  Augmented cross-sectional prevalence testing for estimating HIV incidence.

Authors:  Rui Wang; Stephen W Lagakos
Journal:  Biometrics       Date:  2010-09       Impact factor: 2.571

9.  Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age.

Authors:  Timothy B Hallett; Peter Ghys; Till Bärnighausen; Ping Yan; Geoff P Garnett
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

10.  HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing.

Authors:  Till Bärnighausen; Claudia Wallrauch; Alex Welte; Thomas A McWalter; Nhlanhla Mbizana; Johannes Viljoen; Natalie Graham; Frank Tanser; Adrian Puren; Marie-Louise Newell
Journal:  PLoS One       Date:  2008-11-04       Impact factor: 3.240

View more
  9 in total

1.  Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Hilmarie H Brand; Eric Arts; Immaculate Nankya; Robert A Salata; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-19       Impact factor: 2.205

2.  Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.

Authors:  Sikhulile Moyo; Kenanao P Kotokwe; Terence Mohammed; Corretah Boleo; Lucy Mupfumi; Samuel Chishala; Lesedi Tsalaile; Hermann Bussmann; Simani Gaseitsiwe; Rosemary Musonda; Joseph Makhema; Marianna Baum; Richard Marlink; Susan Engelbrecht; Max Essex; Vladimir Novitsky
Journal:  AIDS Res Hum Retroviruses       Date:  2016-09-07       Impact factor: 2.205

3.  Characteristics of patients recently infected with HIV-1 non-B subtypes in France: a nested study within the mandatory notification system for new HIV diagnoses.

Authors:  Denys Brand; Alain Moreau; Françoise Cazein; Florence Lot; Josiane Pillonel; Sylvie Brunet; Damien Thierry; Stéphane Le Vu; Jean-Christophe Plantier; Caroline Semaille; Francis Barin
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

4.  Modification of AxSYM Human Immunodeficiency Virus Assay to Identify Recent Human Immunodeficiency Virus Infections in Korean Human Immunodeficiency Virus-Positive Individuals.

Authors:  Jin-Sook Wang; Mee-Kyung Kee; Byeong-Sun Choi; Sung Soon Kim
Journal:  Osong Public Health Res Perspect       Date:  2015-06-09

Review 5.  Identifying Recent HIV Infections: From Serological Assays to Genomics.

Authors:  Sikhulile Moyo; Eduan Wilkinson; Vladimir Novitsky; Alain Vandormael; Simani Gaseitsiwe; Max Essex; Susan Engelbrecht; Tulio de Oliveira
Journal:  Viruses       Date:  2015-10-23       Impact factor: 5.048

6.  Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana.

Authors:  Sikhulile Moyo; Alain Vandormael; Eduan Wilkinson; Susan Engelbrecht; Simani Gaseitsiwe; Kenanao P Kotokwe; Rosemary Musonda; Frank Tanser; Max Essex; Vladimir Novitsky; Tulio de Oliveira
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

7.  Pairwise diversity and tMRCA as potential markers for HIV infection recency.

Authors:  Sikhulile Moyo; Eduan Wilkinson; Alain Vandormael; Rui Wang; Jia Weng; Kenanao P Kotokwe; Simani Gaseitsiwe; Rosemary Musonda; Joseph Makhema; Max Essex; Susan Engelbrecht; Tulio de Oliveira; Vladimir Novitsky
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 8.  Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.

Authors:  Shelley N Facente; Eduard Grebe; Andrew D Maher; Douglas Fox; Susan Scheer; Mary Mahy; Shona Dalal; David Lowrance; Kimberly Marsh
Journal:  JMIR Public Health Surveill       Date:  2022-03-11

9.  High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil.

Authors:  Gorki Grinberg; Leila Bertoni Giron; Rosalie Kupka Knoll; Juliana Galinskas; Michelle Camargo; Muhammad Shoaib Arif; Sadia Samer; Luiz Mario Ramos Janini; Maria Cecilia Araripe Sucupira; Ricardo Sobhie Diaz
Journal:  Braz J Infect Dis       Date:  2015-09-09       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.